The Benefits of CELLEX™ Technology - Advancing Knowledge on ECP Technology

Day 1 - 24 septiembre 2025

Arrival of participants

19.00 – 19.30
Meeting in the lobby

19.30
Dinner

Day 2 - 25 septiembre 2025

08.00 – 08.30
Introduction - Prof Jan Simon and Therakos International Healthcare Stakeholders Engagement

08.30 – 09.15
Benefits of THERAKOS™ CELLEX™ Photopheresis System - Clinical Service Therakos

09.15 – 09.45
Venous Access, Best Practices - Prof Mirjana Ziemer

09.45 – 10.00
Buffy Coat – Group 1 - Clinical Service Therakos

09.45 – 10.00
Anticoagulants in ECP – Group 2 - Leipzig team

10.00 – 10.15
Patient Treatment, use of DNM/SNM and ECV management - Leipzig team

10.15 – 10.30
Coffee Break

10.30 – 11.30
Bowl Optic Sensor and Alarm Resolution - Clinical Service Therakos

11.30 – 12.15
Moving toward Excellence in Efficiency - Leipzig team

12.15 – 12.30
Anticoagulants in ECP – Group 1

12.15 – 12.30
Buffy Coat – Group 2 - Clinical Service Therakos

12.30 – 13.15
Lunch

13.15 – 14.30
Patient Treatment and Troubleshooting hints - Leipzig team

DNM: Double Needle Mode, ECP: Extracorporeal Photopheresis, ECV: Extracorporeal Volume
SNM: Single Needle Mode

Please see the THERAKOS CELLEX Photopheresis System Operator Manual for indication,
contraindications, warning, precautions and adverse events.

All speakers are subject to contract.
This is a commercial programme run by Therakos (UK) Ltd, part of Mallinckrodt Pharmaceuticals
This information is intended for healthcare professionals based in Europe and the Middle East.